Literature DB >> 12773874

[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].

J-L Montastruc1, L Schmitt, H Bagheri.   

Abstract

The occurrence of a pathological gambling behavior in a 61-year-old patient with idiopathic Parkinson's disease treated with dopaminergic drugs is reported. This is the first case reported with bromocriptine. The main characteristics and the mechanism of this recently described and a unexpected, adverse drug reaction are discussed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12773874

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN： 0035-3787            Impact factor:   2.607


  5 in total

1.  [Reversible pathological gambling under treatment with pramipexole].

Authors:  K Spengos; E Grips; G Karachalios; G Tsivgoulis; G Papadimitriou
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

Review 2.  Management of psychosis associated with a prolactinoma: case report and review of the literature.

Authors:  Shirin Ali; Karen Klahr Miller; Oliver Freudenreich
Journal:  Psychosomatics       Date:  2010 Sep-Oct       Impact factor: 2.386

Review 3.  Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention.

Authors:  Angelo Antonini; Roberto Cilia
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Dopamine agonists and pathologic behaviors.

Authors:  Brendan J Kelley; Andrew P Duker; Peter Chiu
Journal:  Parkinsons Dis       Date:  2012-04-05

Review 5.  Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.

Authors:  Marie Grall-Bronnec; Anne Sauvaget; Fanny Perrouin; Juliette Leboucher; François Etcheverrigaray; Gaëlle Challet-Bouju; Louise Gaboriau; Pascal Derkinderen; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  J Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.